$14.71
-0.18 (-1.21%)
As of Feb 21, 12:42 AM ET ·
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Buy 6 60%
Hold 4 40%
Sell 0 0%
Price Target
Analyst Price Target +441.5% upside
Low Target $56.38
Average Target $79.65
High Target $102.54
Current Price $14.71
Current
$14.71
Target
$79.65
$56.38 $79.65 avg $102.54
Scenario Analysis
Bear Case
$56.38
283.3%
Low target
Base Case
$79.65
+441.5%
Avg target
Bull Case
$102.54
+597.1%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$30.93
-52.4% from high
52-Week Low
$12.17
+20.9% from low
50-Day SMA
$14.19
+3.7% vs SMA
200-Day SMA
$20.75
-29.1% vs SMA
RSI (14)
65.7
Neutral
Target vs 52W High
$79.65
+157.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Buy 37 73% $1,330.33 +25.7%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +21.8%
MRK
Merck & Co. Inc.
Buy 34 62% $159.27 +28.6%
PFE
Pfizer Inc.
Hold 33 45% $33.90 +25.3%
BMY
Bristol-Myers Squibb Co
Hold 34 41% $174.50 +184.9%
ZTS
Zoetis Inc
Buy 24 67% $209.87 +65.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -18.8%
VTRS
Viatris Inc
Buy 18 61% $122.82 +670.0%